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Regulation of natriuretic peptide (urodilatin) release in a human kid- level, these peptides exert their primary effects by bind-
ney cell line. ing to cell surface receptors with intrinsic guanylyl cy-
Background. To identify the molecular mechanisms underlying the
clase (GC) activity [6]. The extracellular binding of NPsrelease of a renal natriuretic peptide (NP) we selected a human kidney
cell line (HEK 293) that displays several characteristics of distal tubular to the receptor GC leads to the intracellular synthesis
cells. of the second messenger cGMP. Clearance receptorsMethods. Cells were exposed to different extracellular and intracell-
represent another class of high-affinity cell surface recep-ular stimuli, and the effect on NP release was measured with a specific
urodilatin radioimmunoassay, as well as with an atrial NP (ANP) radio- tors for NPs that lack GC activity and mediate internal-
immunoassay. ization and degradation of bound ligand [7].Results. In the absence of stimuli, HEK 293 cells showed a basal
In the 1980s, ANP99–126 obtained wide attention as anrelease of urodilatin immunoreactivity and ANP immunoreactivity.
Raising the osmolality of the secretion medium with sodium chloride important regulator of natriuresis. Recently, however,
and various other osmolytes rapidly increased cellular NP secretion. we showed in many physiological studies that the renalElevation of intracellular cAMP levels by forskolin plus 3-isobutyl-
ANP analogue urodilatin is a more likely candidate for1-methylxanthine and administration of phorbol-12-myristate-13-acetate
together with the calcium-ionophore A23187 also resulted in respective the regulation of sodium excretion, whereas ANP exerts
increases in the amount of secreted peptide. HEK 293 cells exhibit mainly cardiovascular effects [8–11]. Urodilatin was iso-the endogenous expression of both particulate and soluble guanylyl
lated from human urine and was identified as a 32-aminocyclases. In the presence of 8-Br-cGMP, cell cultures showed the en-
hanced secretion of an ANP immunoreactive peptide only, indicating acid peptide consisting of the amino acid sequence 95–
that guanylyl cyclase activation provoked the secretion of ANP immu- 126 of the ANP prohormone [12]. The peptide has not
noreactivity but not of urodilatin immunoreactivity.
been found in plasma [13], suggesting that urodilatinConclusions. The human embryonic kidney cell line HEK 293 repre-
sents a renal cellular model system in which we have identified a rapid is synthesized, processed, and secreted by the kidney.
and regulated release of NPs in response to the osmotic effect of in- Studies have provided evidence that an ANP prohor-
creased extracellular sodium chloride and various intracellular stimuli.
mone-like peptide is produced and secreted by primary
cultures of neonatal and adult rat kidney cells [14]. With
immunohistochemical and immunoassay techniques, itNatriuretic peptides (NPs) play an important role in
was shown that NPs are synthesized in distal corticalthe regulation of body fluids, salt excretion, and blood
tubular cells [15, 16] and that the synthesis is modulatedpressure [1, 2]. They constitute a family of structurally
in some pathophysiological situations in the rat [17, 18].related hormones generating a wide spectrum of vascu-
In human kidney, we have recently found by immunohis-lar, renal, and endocrine actions, all of which serve to
tochemical analysis that urodilatin is present in distalcontrol body fluid homeostasis. Atrial NP (ANP) was
tubular cells (see note added in proof). There have alsothe first isolated member of this peptide family after the
been reports that demonstrated the renal expression ofobservation of natriuretic, diuretic, and vasorelaxant activ-
the gene for ANP in rat kidney, although the ANP mRNAity in rat atrial extracts [3]. Brain NP (BNP) and C-type
is present only at a very low abundance in rat kidneyNP (CNP) represent additional NPs that were both origi-
tissue [18, 19]. All of these observations together suggestnally isolated from porcine brain [4, 5]. On a molecular
that urodilatin is probably produced by distal cortical
tubular cells and is secreted luminally into the urine
to induce natriuresis by interaction with receptor GCs,Key words: human kidney cells, guanylyl cyclase, HEK 239, body fluid
regulation, salt excretion, blood pressure. localized on inner medullary collecting duct cells [20].
In addition to the described NP-sensitive particulateReceived for publication December 9, 1997
GCs, soluble GCs (sGC) represent related cGMP-pro-and in revised form July 8, 1998
Accepted for publication August 8, 1998 ducing enzymes, which are located in the cytoplasm of
cells and are activated by nitric oxide (NO). Recent 1999 by the International Society of Nephrology
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studies indicate that the NO/sGC/cGMP system, in addi- gly20, leu21, gly22)-fragment 4–23 amide (C-ANP4–23) in
tion to the NP/particulate GC system, plays an important order to prevent a loss of the immunoreactive signal
role in the regulation of salt and water transport in the caused by proteolytic degradation or binding of secreted
kidney [21]. peptides to NP clearance receptors. Multiple additions of
Currently, only little information is available concern- these substances every 10 minutes were required because
ing the extracellular and intracellular signals involved in NP immunoreactivity soon declined after an initial rise
the control of NP generation and secretion in the kidney. in single dose experiments. Cell culture supernatants
While the previously mentioned studies showed a close were harvested by aspirating and were transferred into
correlation between natriuresis and urodilatin secretion, prechilled plastic tubes. The tubes were stored at –208C
the regulatory mechanisms underlying the peptide syn- until the determination of NP immunoreactivity in the
thesis and peptide release at the molecular level re- supernatants. Cellular protein content was determined
mained uncertain. We therefore established and charac- by the Lowry method [22] and averaged between 0.9
terized the human kidney cell line HEK 293 as a kidney and 1.6 mg per well.
cell model system in order to study the regulation of
renal NP secretion at the molecular level and to identify Radioimmunoassays
factors that are involved in this regulation.
Urodilatin was measured by radioimmunoassay with a
specific urodilatin antibody displaying no cross-reactivity
METHODS with ANP (ANP99–126), BNP, CNP, ANP prohormone, or
shorter ANP analogues, as described before [13]. Be-Materials
cause of limited availability of this specific urodilatinCell culture media, fetal calf serum, and antibiotics
antibody and the fact that alternative commercial urodi-were purchased from Gibco BRL (Eggenstein, Ger-
latin antibodies could not measure urodilatin in cell su-many). Synthetic human ANP, human urodilatin, human
pernatants because of matrix problems, only key experi-BNP, and human CNP were obtained from Peninsula
ments were performed using the urodilatin antibody.(St. Helens, UK). Human guanylin was from Bachem
ANP immunoreactivity was determined by radioimmu-(Heidelberg, Germany), and human uroguanylin was
noassay with a commercial ANP antibody (Amersham),from Immundiagnostik (Bensheim, Germany). [125I]-iodo-
which showed 100% cross-reactivity with synthetic hu-human ANP99–126 (specific activity 2000 Ci/mmol) was
man urodilatin.obtained from Amersham (Braunschweig, Germany).
Sodium nitroprusside (SNP) was purchased from Merck
Determination of intracellular cGMP production(Darmstadt, Germany). All other chemicals were from
Sigma (Deisenhofen, Germany). Cell culture medium from cells on six-well plastic cell
culture plates was aspirated, and cells were washed twice
Cell culture with prewarmed serum free Dulbecco’s modified Eagle’s
Human embryonic kidney (HEK 293) cells were medium/Nutrient Mix F12 (1:1) without Phenolred, sup-
grown in Dulbecco’s modified Eagle’s medium/Nutrient plemented with 15 mm N-2-Hydroxyethylpiperazine-
Mix F12 (1:1) supplemented with 10% fetal calf serum, N9-2-ethanesulfonic acid. Next, cells were preincubated in
penicillin G (100 U/ml) and streptomycin sulfate (0.1 the same medium, supplemented with 0.5 mm 3-isobutyl-
mg/ml) in a humid atmosphere consisting of 95% air and 1-methylxanthine (IBMX) for 15 minutes at 378C. After
5% CO2 at 378C. For experiments, cells were grown to that, the respective test substances were added to the
near confluence on six-well plastic cell culture plates cell medium, and the plates were incubated for different
(approximately 106 cells per well). Plates had been pre-
times at 378C (3–6 wells for each manipulation). Reac-
coated with poly-l-lysine (Mr . 300,000; 20 mg per well)
tions were terminated by aspirating the cell culture me-to facilitate attachment of the cells to the plastic surface.
dium followed by the addition of 5% trichloroacetic acid
(TCA) to the wells. Wells were then scraped, and TCASecretion of natriuretic peptides from HEK cells
suspensions were separated in pellets and cell extractsCell culture medium from cells on six-well plastic cell
by centrifugation. TCA extracts were re-extracted withculture plates (for each manipulation 3–6 wells) was aspi-
water-saturated diethylether and were afterward lyophi-rated. Then cells were washed twice with 2 ml prewarmed
lized. The cGMP contents of TCA extracts were deter-secretion-medium (140 mm NaCl, 4.3 mm KCl, 2.3 mm
mined after reconstitution of samples in 50 mm sodiumCaCl2, 0.5 mm MgCl2, 1.08 mm KH2PO4, 5.1 mm glucose,
acetate buffer (pH 5.5) by radioimmunoassay as de-0.3% bovine serum albumin, pH 7.4) and were subse-
scribed before [23]. Cellular protein content was deter-quently incubated at 378C in 1 ml of the same medium
mined after solution of cell pellets in 0.8 m NaOH byin the presence of 10 mm phosphoramidon, 10 mm ama-
statin, 2 mg/ml aprotinin and 0.2 nm rat Des-(gln18, ser19, the Lowry method [22].
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Cell characterization: Determination of intracellular effect with a maximal 1.4-, 2.1-, and 2.2-fold increase of
NP immunoreactivity for phosphoramidon, amastatin,cAMP accumulation
and aprotinin, respectively. Additionally, incubation ofCell cultures on six-well plastic cell culture plates were
cells with the NP clearance receptor ligand C-ANP4–23washed and preincubated in the same way as for the
also resulted in an increase in the immmunoreactive sig-determination of cGMP levels. Respective test sub-
nal (twofold), indicating the expression of NP clearancestances were then added to the cell medium, and the
receptors and probably binding of secreted peptide toplates were incubated for 10 minutes at 378C (3–6 wells
these binding sites. In the indicated concentrations, nonefor each manipulation). Determinations were proceeded
of the applied substances showed interference with theincluding the lyophilization of cell extracts as described
urodilatin radioimmunoassay or ANP radioimmunoas-for the determination of cGMP (earlier here). Lyophi-
say, although C-ANP4–23 displayed cross-reactivity withlized samples were reconstituted in 0.2 M phosphate
the ANP radioimmunoassay when used in higher con-buffer containing 0.1% bovine serum albumin, 0.1%
centrations. Surprisingly, the combination-induced effectTween 20, and 0.025% Thimerosal (pH 7.25) and were
lasted only for few minutes, which may have been due tosubsequently succinylated using 11% succinic anhydride
an inactivation of the protective substances themselves,in a 25:9 mixture of acetone/trimethylamine. According
suggesting the requirement for a repeated addition ofto a described nonisotopic immunoassay for cGMP [24],
the protective combination. This assumption was sup-cAMP-contents of samples were determined in 100 ml
ported in our experiments in which substances werealiquots on microtiter plates with a newly developed
added every 10 minutes, and subsequent experimentsfluorescence immunoassay using a polyclonal goat anti-
were performed using the multiple addition of phos-cAMP antibody, rabbit antigoat antiserum (Dako, Ham-
phoramidon, amastatin, aprotinin, and C-ANP4–23 as theburg, Germany) biotinylated cAMP as tracer, europium-
control condition giving a 3.4-fold increase of signal aslabeled streptavidin (Wallac, Freiburg, Germany) and
maximal effect.enhancement solution for detection [25]. The EC50 of
Incubation of the cells with secretion medium con-the assay was 3.92 6 0.69 nm (mean 6 sem).
taining 200 mm NaCl induced a significant increase in
the amount of released urodilatin immunoreactivity inCell characterization: Determination of alkaline
phosphatase activity comparison to control cells incubated with medium con-
taining 140 mm NaCl (Fig. 2; ANOVA, P , 0.01). ToAlkaline phosphatase activity was determined in HEK
evaluate whether this effect was caused either by an293 membranes using p-nitrophenyl phosphate as a sub-
osmotic mechanism of increased extracellular sodiumstrate in an automated analysis (Hitachi system 704;
chloride or by other actions specific for sodium and chlo-Boehringer Mannheim, Mannheim, Germany).
ride ions, we tested various secretion media, each com-
posed of 140 mm NaCl plus either 60 mm NaCl, 60 mmStatistical analyses
choline chloride, 60 mm N-methyl-D-glucamine, 60 mmExperimental data represent means 6 sem of at least
sodium gluconate, or 120 mm mannitol. Figure 3 demon-three determinations performed in triplicate. Results
strates that each of the used osmolytes was able to in-from time-course experiments were analyzed statistically
crease urodilatin secretion significantly when comparedby two-way analysis of variance (ANOVA) for repeated
with control, suggesting that the effect of 200 mm NaClmeasures followed by the one-tailed Student’s t-test for
was due to an increased medium osmolality. The urodi-paired values as post hoc test. P values of ANOVA
latin radioimmunoassay appeared to be slightly influ-given in the results section indicate the significance of
enced by higher osmolyte concentrations. Presented datathe combined effects of treatment on time. Other data
from cell culture supernatants were corrected for thiswere evaluated by the one-tailed Student’s t-test for un-
unspecific immunoreactivity.paired values. P , 0.05 was considered significant.
As shown in Figure 4, forskolin (10 mm) in combination
with 100 mm IBMX as well as phorbol-12-myristate-13-
RESULTS acetate (PMA; 100 nm) together with the calcium-iono-
phore A23187 (0.5 mm) were able to stimulate the releaseThe epithelioid human kidney cell line HEK 293
showed a basal secretion of a renal NP-like substance of immunoreactive material from HEK 293 cells after
five minutes of incubation. This stimulatory effect wasinto cell culture supernatants, which was measured by
both a specific urodilatin and an ANP radioimmunoassay also apparent after 15 minutes, but in contrast, no sig-
nificant difference in comparison to control cells could(Fig. 1). The repeated addition of protease inhibitors to
the secretion medium significantly (ANOVA, P , 0.001) be detected at longer incubation times (30 and 60 min;
data not shown). Figures 1 and 4 also demonstrate thatincreased the immmunoreactive signal, suggesting pro-
teolytic activities for NPs in HEK 293 cells. When tested the used urodilatin immunoassays and ANP immunoas-
says measured rather comparable amounts of secretedindividually, each of the inhibitors exerted a protective
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Fig. 1. Secretion of NP-immunoreactivity from HEK 293 cells. Cell cultures were incubated for the indicated times at 378C with secretion medium
in the absence (h) or presence (j) of 10 mm phosphoramidon, 10 mm amastatin, 2 mg ml21 aprotinin and 0.2 nm C-ANP4–23. Addition of solvent
(h) or the combination of phosphoramidon, amastatin, aprotinin and C-ANP4–23 (j) in the above indicated final concentrations was repeated
every 10 minutes. Immunoreactive peptide was determined in cell culture supernatants with (A) an urodilatin-specific and (B) with an ANP-
radioimmunoassay. *P , 0.05; **P , 0.01; ***P , 0.001.
Fig. 3. Stimulation of urodilatin secretion by hyperosmolality. Cell cul-
tures were incubated for 5 and 60 minutes at 378C with secretion media
containing 140 mm NaCl (h) plus either 60 mm NaCl (j), 60 mm
Fig. 2. Effect of sodium chloride on urodilatin secretion in HEK 293 choline chloride ( ), 60 mm N-methyl-D-glucamine ( ), 60 mm sodium
cells. Cell cultures were incubated for the indicated times at 378C with gluconate ( ) or 120 mm mannitol ( ). Incubations were performed
secretion medium containing either 140 mm NaCl (n) or 200 mm NaCl in the presence of 10 mm phosphoramidon, 10 mm amastatin, 2 mg ml21
(m). Incubations were performed in the presence of 10 mm phosphorami- aprotinin and 0.2 nm C-ANP4–23. Urodilatin was determined in cell culture
don, 10 mm amastatin, 2 mg ml21 aprotinin and 0.2 nm C-ANP4–23. Urodi- supernatants with a urodilatin specific radioimmunoassay. *P , 0.05;
latin was determined in cell culture supernatants with a urodilatin spe- **P , 0.01; ***P , 0.001.
cific radioimmunoassay. *P , 0.05; **P , 0.01.
In HEK 293 cells, the expression of NP-sensitive GCs
could be demonstrated by the stimulation of intracellularimmunoreactive substances, indicating that untreated cells
and cells challenged with the applied stimuli secrete urodi- cGMP accumulation in response to different NP receptor
ligands. Figure 5A shows the dose–response curves forlatin rather than ANP99–126 or other ANP derivatives.
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Fig. 4. Regulation of NP secretion from HEK 293 cells. Cells were incubated for 5 minutes at 378C in the absence (h) or presence of either 100
nm PMA/500 nm A23187 or 10 mm forskolin/100 mm IBMX (j). Incubations were performed in the presence of 10 mm phosphoramidon, 10 mm
amastatin, 2 mg ml21 aprotinin and 0.2 nm C-ANP4–23. Urodilatin (A) and ANP (B) immunoreactivities were determined in cell culture supernatants
with ANP and urodilatin radioimmunoassays, respectively. *P , 0.05
Fig. 5. Stimulation of cGMP accumulation in HEK 293 cells. (A) Cells were preincubated for 15 minutes with 0.5 mm IBMX and then treated
for 30 minutes with solvent (Basal) or with the indicated concentrations of ANP (d), urodilatin (h), BNP (m), CNP (e), guanylin (s) or
uroguanylin (.). (B) Cells were preincubated for 15 minutes with 0.5 mm IBMX and then treated for 5 minutes with solvent (Basal) or with the
indicated concentrations of YC-1 (n), SNP (j) or SIN-1 (,). Intracellular cGMP levels were determined as described in the methods.
ANP99–126, urodilatin, BNP, CNP, guanylin, and urogua- out any effect. These results indicate that HEK 293 cells
exhibit the endogenous expression of GC type A, whichnylin. Whereas ANP99–126, urodilatin, and BNP elicited a
dose-dependent increase of cGMP levels with EC50-values is stimulated by ANP99–126, urodilatin, and BNP. The EC50
value for ANP99–126 was found to be significantly lowerof 3.4 6 0.2 nm, 45.5 6 1.1 nm, and 92.9 6 23.1 nm,
respectively, CNP, guanylin, and uroguanylin were with- when compared with the EC50 values for urodilatin and
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Fig. 6. Effect of 8-Br-cGMP on NP secretion in HEK 293 cells. Cells were incubated for the indicated times at 378C with solvent (s) or with
1 mm 8-Br-cGMP (d). Incubations were performed in the presence of 10 mm phosphoramidon, 10 mm amastatin, 2 mg ml21 aprotinin and 0.2 nm
C-ANP4–23. Urodilatin- (A) and ANP- (B) immunoreactivities were determined in cell culture supernatants with ANP and urodilatin radioimmunoas-
says, respectively. *P , 0.05; **P , 0.01; ***P , 0.001
BNP, respectively (P , 0.01; t-test). Neither GC type B, and values were thus corrected for this unspecific immu-
noreactivity.which is specifically activated by CNP, nor the guanylin-
and uroguanylin-sensitive GC type C appear to be pres- HEK 293 cells were also characterized with regard to
the retention of properties specific for renal tubular cells.ent in HEK 293 cells. In order to test for the presence
of sGC, HEK 293 cells were incubated with the NO- Cell cultures were investigated for their ability to re-
spond to various renal-acting hormones with an elevationdonors SNP, SIN-1, and YC-1, a novel NO-independent
stimulator of sGC (Fig. 5B). YC-1 was shown to be most of intracellular cAMP levels. Compared with the basal
level (12.7 6 1.9 pmol/mg protein), marked stimulationeffective displaying an EC50 of 0.13 6 0.013 mm and a
59-fold stimulation of intracellular cGMP accumulation of cellular cAMP production was observed in response
to 10 mm forskolin (324.6 6 32.2 pmol/mg protein), 1 mmover basal at a concentration of 1 mm. SNP and SIN-1
both stimulated cGMP accumulation to a lesser extent; vasoactive intestinal peptide (VIP; 841.0 6 67.2 pmol/
mg protein), and 10 mm isoproterenol (248.0 6 23.8 pmol/maximal stimulations seen with concentrations of 1 mm
were 43-fold for SNP and 14-fold for SIN-1. mg protein). These results suggest the presence of both
VIP- and isoproterenol-sensitive adenylyl cyclases inTo examine whether the activation of GCs plays a
role in the regulation of renal NP secretion, HEK 293 HEK 293 cells, which were shown previously to be re-
stricted to distal nephron sites [26, 27]. Parathyroid hor-cells were treated with a cell-permeable cGMP analogue
or with the NO donor SNP. 8-Br-cGMP (1 mm) rapidly mone at 1 mm elicited a 2.4-fold increase (30.6 6 1.1
pmol/mg protein) over basal cAMP levels, whereas 1 mmenhanced the amount of secreted ANP immunoreactiv-
ity, and this stimulatory effect could be observed over a [Arg8]vasopressin (AVP) had no effect (8.9 6 0.6 pmol/
mg protein), which is—in contrast to the AVP-respon-total incubation time of 60 minutes (Fig. 6B; ANOVA,
P , 0.01). SNP (1 mm) was likewise able to induce a sive collecting duct—indicative in particular for distal
convoluted tubules of the human nephron [26]. HEKcomparable 1.9-fold increase of the released ANP immu-
noreactivity. Surprisingly, no significant increase of im- 293 cells were further characterized in view of the expres-
sion of alkaline phosphatase, which represents an en-munoreactive material could be detected in the same
experiments with the urodilatin-specific radioimmunoas- zyme typically found in the brush border region of proxi-
mal tubular cells. In prepared membranes from HEKsay (ANOVA, P 5 0.172), suggesting that 8-Br-cGMP
or SNP stimulated the release of ANP (Fig. 6B), but not 293 cells, a low level alkaline phosphatase activity of 15 6 3
mU/mg protein was measured, whereas isolated culturedof urodilatin (Fig. 6A). The ANP radioimmunoassay was
shown to be slightly influenced by 8-Br-cGMP, giving a human proximal tubular cells showed an activity of 114 6
29 mU/mg protein [28].background signal of approximately 14 fmol/mg protein,
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DISCUSSION messenger systems in the regulation of renal NP secre-
tion. It was found that both a stimulator of PKC (PMA)In this study, we have presented a human kidney cell
in combination with the calcium-ionophore A23187, asline (HEK 293 cells) as a cellular model system, dis-
well as the activation of adenylyl cyclase with subsequentplaying synthesis, release, and elimination of a renal NP.
rise of intracellular cAMP levels induced by forskolinThis suggests that the human kidney may be able to
and IBMX, were able to stimulate the rapid release ofregulate the intrarenal NP processing in response to cer-
immunoreactive material from HEK 293 cells. In com-tain extracellular and intracellular stimuli such as eleva-
parison to this, PMA and A23187 were also shown totion of the extracellular sodium chloride concentration,
stimulate ANP secretion in the perfused spontaneouslyactivation of adenylyl cyclase, protein kinase C (PKC),
beating rat heart [30], suggesting a common regulatoryand increasing intracellular calcium concentrations in
role of PKC and intracellular calcium in renal as well asorder to maintain the water and electrolyte homeostasis.
in cardiac cells. Additionally, the intracellular cAMPThe addition of a combination consisting of the specific
level may likewise be involved in modulating the releaseneutral endopeptidase inhibitor phosphoramidon, the
of NPs from both the kidney cells and the atrial cardio-aminopeptidase inhibitor amastatin, and the protease
cytes as has been demonstrated by the ability of forskolininhibitor aprotinin to the secretion medium resulted in
to increase the ANP secretion from the perfused ratan increase of NP immunoreactivity in cell culture super-
heart [31]. Furthermore, it was shown in rat adult renalnatants, suggesting proteolytic activities for NPs in HEK
cortical cell cultures that after a 24 hour treatment, PMA293 cells. The NP clearance receptor ligand C-ANP4–23 or forskolin had either no effect or even decreased thewas also able to elevate the immunoreactive signal when
release of an ANP-like peptide in the culture mediumadded to the culture medium. This finding suggests the
[15]. Consistently, the observed stimulatory effects withexistence of non–GC-coupled NP receptors on the sur-
PMA or forskolin in this study were apparent only afterface of HEK 293 cells and probably binding of secreted
relatively short incubation times of 5 and 15 minutes,peptide to these binding sites, thus reducing the amount
whereas longer incubation times (30 and 60 min) did not
of detectable peptide in the supernatant. Dynamic regu-
display any effect.
lation of both the proteolytic activity and the number of Because the stimulatory effects of elevated sodium
clearance receptors may provide additional mechanisms chloride, as well as of PMA/A23187 and forskolin/
by which bioactivity of secreted peptides is modulated. IBMX, could already be observed after five minutes of
Further studies are required to identify in HEK 293 cells incubation, it seems very unlikely that the increase of
the exact mechanisms of NP-immunoreactivity decrease secreted peptide is due to enhanced gene expression and
and the involved proteins. de novo protein synthesis. More probably, HEK 293 cells
Recent physiological studies have provided evidence appear to be capable of storing a certain amount of NPs
that urodilatin secretion is very closely correlated with in an intracellular compartment prior to the release in
renal sodium excretion under various conditions [8–11]. response to an appropriate stimulus. Alternatively, it
This study supports the assumption of an interaction may be that certain transport processes of the constitu-
between urodilatin release and renal sodium handling, tive secretion pathway become enhanced after adminis-
showing that an elevation of the extracellular sodium tration of respective stimuli, resulting in the observed
chloride concentration increased the secretion of urodi- increase in peptide secretion. Other studies are in con-
latin immunoreactive material from the cultured kidney trast to the first hypothesis, showing little or no storage
cells. Further evidence for an influence of the extracellu- capacity for a renal NP-like protein in neonatal rat kid-
lar sodium chloride concentration on NP release was ney cells and accordingly favoring a constitutive secre-
reported in a recent study that showed that on the other tion of peptides from these cells [14]. In this work, how-
hand, a reduction of the sodium chloride concentration ever, only secretion studies of 5 to 24 hours were
from a normal (140 mm) to a subphysiological level (120 performed, whereas the results from short-term incuba-
mm) decreased urodilatin secretion from HEK 293 cells tions in the range of 5 to 60 minutes were not reported.
[29]. Our results with various other osmolytes suggest With respect to time, our findings do not exclude the
that the effect of 200 mm NaCl was due to an increased possibility of dual regulatory mechanisms underlying the
osmotic pressure on the cells. Because a hyperosmotic secretion of renal NPs at early and late incubation times,
cellular environment will induce water transport from respectively. The observed increase of secreted urodi-
the intracellular site to the extracellular medium, it may latin immunoreactivity seen after a 60-minute treatment
also represent a physiological stimulus for the transport with 200 mm NaCl may therefore be composed of an
of NP from internal to external sites of the cell. enhanced rapid secretion from intracellular stores plus
The molecular mechanisms linking extracellular sig- an enhanced synthesis, followed by a constitutive secre-
nals to NP release in the kidney are not known. For tion of peptide.
Beside the obvious synthesis and secretion of a renalthat reason, we studied the role of different second-
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NP, HEK 293 cells seem to express receptors for these which also agrees well with the reported localization of
ANP or urodilatin synthesizing cells [16]. In this study,ligands, therefore displaying characteristics of autocrine
cells. Our results suggest that HEK 293 cells express we showed that HEK 293 cells exhibit a VIP-sensitive
and an isoproterenol-sensitive adenylyl cyclase, whichfunctional GC-coupled receptors, namely GC type A
but neither type B nor type C, which are considered to were both shown previously to be restricted to distal
nephron sites [26, 27]. Because the cell line appears tobe activated by CNP and the guanylins, respectively.
Many studies have shown that ANP99–126 and urodilatin be completely unresponsive to AVP and this effect has
also been reported for the human distal convoluted tu-act through their receptor with equivalent potencies. In
this work, however, urodilatin displayed an approximate bule [26], it seems very likely that HEK 293 cells may
be derived from this part of the nephron and that the10-fold higher EC50 in its potency to stimulate cGMP
accumulation than ANP99–126. This may have been due cells display the retention of both the unresponsiveness
to vasopressin and the secretion of a renal NP. Theto a post-translational modification of the NP receptor
molecule, as has been shown previously [32]. As we con- observation that HEK 293 cells contain only low levels of
alkaline phosphatase activity in comparison to culturedsider the HEK 293 cell line to be primarily related to
NP-secreting distal cortical tubular cells (see below), the human proximal tubular cells additionally supports the
distal character of HEK 293 cells.comparison of HEK 293 EC50-values may not reflect the
conditions at the in vivo target cells for urodilatin, which In summary, we have demonstrated that HEK 293 cells
secrete a renal NP-like substance that displays urodilatinare thought to be localized mainly in the medullary col-
lecting duct. By incubating HEK 293 cells with the NO immunoreactivity. The release of this urodilatin-like sub-
stance was shown to be modulated in response to variousdonors SNP and SIN-1 as well as with the novel benzyl
indazole derivative YC-1, it was shown that the HEK extracellular and intracellular stimuli, including the stim-
ulation by a hyperosmotic concentration of sodium chlo-293 cell line expresses sGC as another cGMP-generating
enzyme. To investigate the involvement of cellular GCs ride. Furthermore, the cell line appears to be capable
of metabolizing or eliminating secreted NPs. Therefore,in the regulation of renal NP secretion, 8-Br-cGMP was
applied to the cells as a membrane-permeable analogue HEK 293 cells may represent an in vitro model for a
regulated intrarenal processing of NPs in the kidney,of the second messenger cGMP. The analogue was
shown to increase the amount of secreted ANP immuno- which may then exert its autocrine or paracrine effects
on renal electrolyte and water excretion.reactivity from HEK 293 cells, indicating that GC activa-
tion may be involved in the regulation of renal NP re-
lease. Because SNP was found to be comparably effective
NOTE ADDED IN PROOF
to 8-Br-cGMP, it can be concluded that the NO-stimu-
Herten M, Lenz W, Gerzer R, Drummer C: The renal natriuretic
lated sGC represents a system that is able to modulate peptide urodilatin is present in human kidney. Nephrol Dial Transplant
13:2529–2535, 1998the secretion of NPs in the kidney. The extent to which
the stimulation of particulate GCs will exert similar ef-
fects remains to be examined in future studies. ACKNOWLEDGMENTS
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